Association between complete skin clearance (psoriasis area and severity index 100) and drug survival of biologics in patients with chronic plaque psoriasis: A single-center retrospective study - 16/09/23
Doi : 10.1016/j.jaad.2023.06.022
Won Ji Song, MD a, Hyun-Sun Yoon, MD, PhD b, c, ⁎ 
a Department of Dermatology, Seoul National University Hospital, Seoul, Korea
b Department of Dermatology, SMG-SNU Boramae Medical Center, Seoul, Korea
c Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea
∗Correspondence to: Hyun-Sun Yoon, MD, PhD, Department of Dermatology, SMG-SNU Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul, KoreaDepartment of DermatologySMG-SNU Boramae Medical Center20 Boramae-ro 5-gil, Dongjak-guSeoulKorea
| Funding sources: None. |
|
| IRB approval status: Reviewed and approved by the IRB of SMG-SNU Boramae Medical Center (IRB No. 30-2021-03). The requirement for obtaining informed consent was waived by the IRB. |
© 2023
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 89 - N° 4
P. 848-851 - ottobre 2023 Ritorno al numero
Articolo precedente
- Risk factors for generalized pustular psoriasis: A case-control study
- Nicole Mastacouris, Abigail Feda, Andrew Strunk, Amit Garg
- Hepatitis B vaccination in patients with psoriasis
- Wonder Edem, Shamieh Banihani, Amylee Martin, Jashin J. Wu
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?